Childhood Cancer Survivors Clinical Trial
— PAPAYAOfficial title:
Physical Activity Post-Cancer for Adolescents and Young Adults (PAPAYA)
Verified date | August 2023 |
Source | Milton S. Hershey Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Physical Activity Post-Cancer for Adolescents and Young Adults (PAPAYA) trial aims to carry out a pilot randomized controlled trial among 10-17 year-old adolescents and young adults, at least 1 year and up to 5 years post-cancer treatment. The trial will evaluate the effects of a 12 week physical activity intervention to improve patient reported outcomes and physical function, in comparison to a delayed-intervention control group.
Status | Completed |
Enrollment | 40 |
Est. completion date | August 1, 2023 |
Est. primary completion date | February 27, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 10 Years to 17 Years |
Eligibility | Inclusion Criteria: Adolescent and young adult inclusion criteria will be as follows: 1. males and females diagnosed with cancer; 2. treated at Penn State Health Children's Hospital or Penn State Cancer Institute, Milton S. Hershey Medical Center; 3. at least 1 year and up to 5 years post-cancer treatment; 4. being aged between 10 to 17 years old at enrollment; 5. being able to speak, read and understand the English language; 6. adolescents and young adults have to be able to assent, and parents/guardians have to be able to consent to the study in an informed manner; 7. Parent fluency in written and spoken English; 8. Adolescents and young adults or their parents must have access to a phone or Zoom Note: The agreement of the attending oncologist will be required for the participation of adolescents and young adults eligible for this study. Exclusion Criteria: Adolescent and young adult exclusion criteria will be as follows: 1. Received follow-up at a location other than Penn State Health Children's Hospital or Penn State Cancer Institute, Milton S. Hershey Medical Center; 2. Evidence in the medical record of an absolute contraindication for physical activity; 3. cardiac exclusion criteria: Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system, history of acute coronary syndromes, uncertain or uncontrolled arrhythmia, uncontrolled hypertension, syncope, acute myocarditis, pericarditis, or endocarditis, acute pulmonary embolus or pulmonary infarction, thrombosis of lower extremities, suspected dissecting aneurysm, pulmonary edema, respiratory failure, acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise, mental impairment leading to inability to cooperate; 4. History of refractory or recurrent diseases 5. Already meeting physical activity guidelines. |
Country | Name | City | State |
---|---|---|---|
United States | Penn State Health Milton S. Hershey Medical Center | Hershey | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Milton S. Hershey Medical Center | Four Diamonds Research Fund at Penn State Health Childrens Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Costs | Cost of carrying out the intervention will be also a secondary endpoint. We will include staff time, space, and equipment in our estimation of cost per patient to carry out the intervention | Baseline to week 12 | |
Other | Demographics | At baseline, assented/consented adolescents and young adults will be asked to complete the demographic questionnaires about age (years), sex (male or female), ethnicity (white or black or Asian or Hispanic other/mixed), education level. Adolescents and young adult participants will also be asked age at diagnosis (years), time since diagnosis (months) and diagnosis. Also, treatment interventions including cranial radiation (yes or no) and chemotherapy (yes or no) will be obtained. Adolescents and young adults will be asked if they are currently receiving any mental health-related treatment and/or intervention. | baseline | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
Baseline | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 1 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 2 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 3 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 4 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 5 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 6 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 7 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 8 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 9 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 10 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 11 | |
Other | Physical activity-Godin-Shephard Leisure-Time Physical Activity Questionnaire (process outcome) | Physical activity will be assessed by a self-reported, 4-item questionnaire. This questionnaire will be administered over the telephone or HIPAA compliant ZOOM weekly. Weekly frequencies of strenuous, moderate, and light activities are reported, and using a standardized formula, total weekly leisure activity is calculated.
Less than 14 units: Insufficiently active 14 to 23 units: Moderately active 24 units or more: Active |
week 12 | |
Primary | Acceptability-the proportion of adolescents and young adults who agree to participate | The proportion of adolescents and young adults who agree to participate among those deemed eligible by the attending oncologist
Range 0-100%-Higher scores indicate greater acceptability |
Baseline | |
Primary | Feasibility-the proportion of adolescents and young adults who complete at least 50% of the physical activity intervention | The percentage of those randomized to the physical activity intervention that complete at least 50% of the physical activity intervention. Participants will be instructed by a project manager during weekly support calls to accumulate a specific amount of physical activity each week. Participants who self-report completing at least 50% of the physical activity, determined by the Godin-Shephard Leisure-Time Physical Activity Questionnaire, will be deemed compliant.
Range 0-100%-Higher scores indicate greater feasibility |
Baseline to week 12 | |
Secondary | Patient reported outcomes-physical function mobility | the physical function mobility assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater physical function mobility |
Baseline | |
Secondary | Patient reported outcomes-physical function mobility | the physical function mobility assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater physical function mobility |
week 12 | |
Secondary | Patient reported outcomes-anxiety | the anxiety assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater anxiety |
Baseline | |
Secondary | Patient reported outcomes-anxiety | the anxiety assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater anxiety |
Week 12 | |
Secondary | Patient reported outcomes-depressive symptoms | the depressive symptoms assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater depressive symptoms |
baseline | |
Secondary | Patient reported outcomes-depressive symptoms | the depressive symptoms assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater depressive symptoms |
Week 12 | |
Secondary | Patient reported outcomes-fatigue | the fatigue assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater fatigue |
baseline | |
Secondary | Patient reported outcomes-fatigue | the fatigue assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater fatigue |
week 12 | |
Secondary | Patient reported outcomes-peer relationships | the peer relationships assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater peer relationships |
baseline | |
Secondary | Patient reported outcomes-peer relationships | the peer relationships assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater peer relationships |
week 12 | |
Secondary | Patient reported outcomes-social isolation | the social isolation assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater social isolation |
baseline | |
Secondary | Patient reported outcomes-social isolation | the social isolation assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater social isolation |
week 12 | |
Secondary | Patient reported outcomes-pain interference | the pain interference assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater pain interference |
baseline | |
Secondary | Patient reported outcomes-pain interference | the pain interference assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater pain interference |
week 12 | |
Secondary | Patient reported outcomes-pain intensity | the pain intensity assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 0-10, higher scores indicate greater pain intensity |
baseline | |
Secondary | Patient reported outcomes-pain intensity | the pain intensity assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 0-10, higher scores indicate greater pain intensity |
week 12 | |
Secondary | Patient reported outcomes-sleep disturbance | the sleep disturbance assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater sleep disturbance |
baseline | |
Secondary | Patient reported outcomes-sleep disturbance | the sleep disturbance assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 8-40, higher scores indicate greater sleep disturbance |
week 12 | |
Secondary | Patient reported outcomes-cognitive function | the cognitive function assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 7-35, higher scores indicate greater cognitive function |
baseline | |
Secondary | Patient reported outcomes-cognitive function | the cognitive function assessment domain from the PROMIS (Patient-Reported Outcomes Measurement Information System Pediatric Profile v2.0-Profile-49)
Range 7-35, higher scores indicate greater cognitive function |
week 12 | |
Secondary | physical function-six minute walking test | The six minute walking test will be administered to assess physical function. Participants will aim to walk as far as possible for 6 minutes.
Further distances indicate greater physical function |
baseline | |
Secondary | physical function-six minute walking test | The six minute walking test will be administered to assess physical function. Participants will aim to walk as far as possible for 6 minutes.
Further distances indicate greater physical function |
week 12 | |
Secondary | physical function-30 second chair stand | The 30 second chair stand test will be administered to assess physical function. Participants will aim to sit and rise out of a chair as many times as possible in 30 seconds.
Greater amounts of sit/stands indicate greater physical function |
baseline | |
Secondary | physical function-30 second chair stand | The 30 second chair stand test will be administered to assess physical function. Participants will aim to sit and rise out of a chair as many times as possible in 30 seconds.
Greater amounts of sit/stands indicate greater physical function |
week 12 | |
Secondary | physical function-timed up and go | The timed up and go test will be administered to assess physical function. Participants will aim to stand up, walk 3 meters, turn around, and walk back to the chair as fast as possible.
Shorter durations indicate greater physical function |
baseline | |
Secondary | physical function-timed up and go | The timed up and go test will be administered to assess physical function. Participants will aim to stand up, walk 3 meters, turn around, and walk back to the chair as fast as possible.
Shorter durations indicate greater physical function |
week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05562193 -
Exercise and Pain in CCS
|
N/A | |
Withdrawn |
NCT01948232 -
Pilot Study of Perindopril in Childhood Cancer Survivors
|
Phase 2 | |
Completed |
NCT04075734 -
Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors
|
N/A | |
Completed |
NCT05641636 -
Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors
|
||
Recruiting |
NCT02355340 -
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
|
||
Recruiting |
NCT05527392 -
Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)
|
N/A | |
Completed |
NCT04520061 -
Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer
|
N/A | |
Recruiting |
NCT03523377 -
Overnight Fasting After Completion of Therapy: The OnFACT Study
|
N/A | |
Recruiting |
NCT05463796 -
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
|